Biogen buys Nightstar in search of more eye gene therapies - BioPharma Dive
Biogen buys Nightstar in search of more eye gene therapies BioPharma Dive Eyeing a deeper pipeline of ophthalmology gene therapies, Biogen said Monday it intends to acquire Nightstar Therapeutics for